Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

I don't disagree that he wanted to be paid, and maybe he is even a little greedy. However, why would shareholders expect execs from successful biotech companies to come into a tiny company on the verge of insolvency and save it from the dustbin without obtaining any stake in the game? That's just somewhat unrealistic, and it's not how business works. Management has executed the vaccine development very well. The fact that a clinical biotech has to raise money is also a fact of business, and to attribute some sinister motive to it with no evidence other than "he's a snake" may be convenient but that doesn't make it accurate. I'll never understand people who invest in clinical biotechs and then seem surprised that dilution occurs and that the stock gets manipulated (which they attribute to some imagined fundamental cause). Capital raising and stock manipulation are both a given in this space.